The Science Behind Nerium SkinCare (Nov. 2013)

The Science Behind:
Nerium SkinCare

Nerium SkinCare is dedicated to “evidence-based” product
development. Quite simply, the company believes that preclinical
and clinical testing of its products is essential prior to the release of
a given product to the public. Nerium SkinCare does not rely merely
on published work by others, but provides for appropriately designed
studies of its own to insure safety and efficacy.
When asked to describe the precautions and protocols that Nerium
SkinCare uses to ensure it meets all safety standards, Dr. Robert
Newman, scientific advisor to Nerium SkinCare, responded, “Both
preclinical and clinical safety testing is performed on Nerium SkinCare
products. Importantly, this is NOT done using animals. Rather, the
research relies on in vitro cell culture, as well as actual human clinical
studies. The clinical studies are carried out in volunteers, typically using
small, defined areas of skin or other target tissue sites, which include
additional safety precautions utilizing blood chemistry’s and CBC
analysis for each participant. Once safety is assured, larger scale
clinical testing and analysis is then done.”

The skincare market
is filled with products
that have little, if
any, evidence-based
research behind them.
Nerium SkinCare’s
philosophy stands in
stark contrast to that.

The skincare market is filled with products that have little, if any,
evidence-based research behind them. Often, what is saved in terms
of research simply goes into marketing. Nerium SkinCare’s philosophy
stands in stark contrast to that, as the company will not release
any product without safety and evidence-based proof of product
performance and efficacy.
The discovery of using Nerium oleander in a skincare capacity was
truly accidental. Following this finding, scientific steps were taken to
create a product harnessing the power of Nerium oleander. This process
included the selection of appropriate product components (such as
aloe), development of innovative technology related to the extraction
of Nerium oleander leaves, unique blending of the aloe-based oleander
extract into a useful cream-based cosmetic product, safety testing, and
preclinical and clinical testing to assure product efficacy and utility.

Robert A. Newman, Ph.D. Chairman of the Scientific Advisory Board
Dr. Newman obtained his M.S. and Ph.D. degrees in Pharmacology and Toxicology from the
University of Connecticut and then served in postdoctoral positions at the Medical School
of the University of Georgia, as well as the Department of Biochemistry at the University of
Vermont. He served as a faculty member at the University of Vermont Medical School for
seven years and then spent a sabbatical year at Stanford University performing research on
immune targeted therapy. He has spent the last 24 years at the University of Texas M. D.
Anderson Cancer Center in Houston, Texas, where he served as the Founder and Co-Director
of the Pharmaceutical Development Center. He has published over 300 articles dealing with
the pharmacology, toxicology, and development of anticancer drugs. Dr. Newman remains
actively involved in continuing research as Scientific Advisor to Nerium Biotechnology, Inc.

©2012 NeriumTM International. All Rights Reserved. Revised 8/12.